Cobat A

Autoantibodies neutralizing type I IFNs in patients with fulminant herpes simplex virus hepatitis.

Gervais A, Marchal A, Boucherit S, ..., Casanova JL, Jouanguy E

J. Exp. Med. 223 (3) - [2026-03-02; online 2025-12-05]

Deleterious variants in the autophagy-related gene RB1CC1/FIP200 impair immunity to SARS-CoV-2.

Hu L, van der Sluis RM, Castelino KB, ..., Paludan SR, Mogensen TH

Nat Commun 16 (1) 10618 [2025-11-27; online 2025-11-27]

Human LY9 governs CD4+ T cell IFN-γ immunity to Mycobacterium tuberculosis.

Ogishi M, Puchan J, Yang R, ..., Boisson-Dupuis S, Casanova JL

Sci Immunol 10 (107) eads7377 [2025-05-30; online 2025-05-30]

Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases.

Rosain J, Le Voyer T, Liu X, ..., Anderson MS, Casanova JL

J. Exp. Med. 221 (11) - [2024-11-04; online 2024-10-01]

The immunopathological landscape of human pre-TCRα deficiency: From rare to common variants.

Materna M, Delmonte OM, Bosticardo M, ..., Casanova JL, Béziat V

Science (New York, N.Y.) 383 (6686) eadh4059 [2024-03-00; online 2024-03-01]

Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency.

Le Voyer T, Parent AV, Liu X, ..., Casanova JL, Puel A

Nature 623 (7988) 803-813 [2023-11-00; online 2023-11-08]

Human genetic and immunological determinants of critical COVID-19 pneumonia.

Zhang Q, Bastard P, COVID Human Genetic Effort , Cobat A, Casanova JL

Nature 603 (7902) 587-598 [2022-03-00; online 2022-01-28]

Autoantibodies against type I IFNs in patients with life-threatening COVID-19.

Bastard P, Rosen LB, Zhang Q, ..., Su HC, Casanova JL

Science (New York, N.Y.) 370 (6515) - [2020-10-23; online 2020-09-24]